Harvard Medical School Q-FASTR logo
Harvard Q-FASTR Therapeutics Acceleration Grants

Q-FASTR Development Award

Funds Harvard biomedical investigators through sustained support to reach preclinical milestones.

ClosedHarvard Medical School Q-FASTRUnited States
View on funder site
About

The Q-FASTR Development Award is the larger of two grant tracks administered by Q-FASTR (Quadrangle Fund for Advancing and Seeding Translational Research) at Harvard Medical School's Innovation Hub, established in 2014 with initial support from Phill Gross and matched funding from the Warren Alpert Foundation and Barbara and Louis Perlmutter. Development Awards provide up to $300,000 in direct cos…

What this grant funds

Advanced-stage preclinical development: chemical or biological compounds showing activity in validated preclinical models, with a clear path to clinical or commercial development.

Key facts
CycleiHow often this grant runs — e.g. annually, on a rolling basis, or a one-off call.Annual
Next deadlineiThe next date applications are due. Rolling means you can apply any time.—
Decision timeiTypical time from the deadline to the funder's decision.—
Project durationiHow long the funded work is expected to run.null–24 months
Award typeiThe form of funding — grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.0%
Funding pooliThe total budget available across all awards in this round.—
Funding analytics

Sign up free to see the funding breakdown

Create free accountSign in
Industries

Sign up free to see the industries in scope

Create free accountSign in
Eligibility criteria

Sign up free to see the full eligibility

Create free accountSign in
Application process

Sign up free to see how to apply

Create free accountSign in
What you have to submit

Sign up free to see what you submit

Create free accountSign in
Timeline

Sign up free to see the timeline

Create free accountSign in
Last verified: 24 Jul 2026Source: qfastr.hms.harvard.edu